Showing 6201-6210 of 19385 results for "".
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
https://reachmd.com/programs/project-oncology/ribosome-maturation-triple-negative-breast-cancer/48768/Triple-negative breast cancer (TNBC) remains one of the hardest subtypes to treat, with limited options and high relapse rates—so identifying new therapeutic targets is critical. In this AudioAbstract, Ryan Quigley spotlights research presented at the San Antonio Breast Cancer Symposium that implicaVomiting Syndromes: A Closer Look at CVS and CHS in Adult Patients
https://reachmd.com/programs/gi-insights/vomiting-syndromes-a-closer-look-at-cvs-and-chs-in-adult-patients/36498/Cyclic vomiting syndrome (CVS) is often underdiagnosed in adults due to its episodic nature and symptom overlap with other conditions. Dr. David Levinthal joins Dr. Peter Buch to explore key diagnostic criteria, key differences between CVS and cannabinoid hyperemesis syndrome (CHS), and evidence-Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
https://reachmd.com/programs/neurofrontiers/duchenne-muscular-dystrophy-management-analyzing-current-approaches/32360/Hear expert insights on how symptomatic care and emerging gene therapies can improve outcomes for patients with Duchenne muscular dystrophy.Anesthesia Technique & Cancer Recurrence: What Do We Need to Know?
https://reachmd.com/programs/project-oncology/anesthesia-technique-cancer-recurrence-what-do-we-need-to-know/13476/Can general anesthesia impact cancer recurrence and outcomes?AFFIRM-AHF: Key Takeaways
https://reachmd.com/programs/global-heart-failure-academy/affirm-ahf-key-takeaways/12005/Find out what the latest data from the AFFIRM-AHF trial tell us about treatment with intravenous iron in patients with acute heart failure.HIPEC: A Novel Treatment for Advanced Abdominal Cancers
https://reachmd.com/programs/advanced-treatments-innovations-mayo-clinic/hipec-novel-treatment-advanced-abdominal-cancers/11175/For cancers within the abdomen, a cure is rare because it’s hard to get chemotherapy to reach those areas. But that’s not the case with HIPEC.High Price: How A Neuroscientist's Journey of Self-Discovery is Challenging Society's Perception on Drugs
https://reachmd.com/programs/book-club/high-price-a-neuroscientists-journey-of-self-discovery-is-challenging-societys-perception-on-drugs/10017/Dr. Carl Hart shows how personal experience and scientific study can inform each other for a deeper understanding of human behavior and addiction.Video: Using Endosee for Diagnostic Hysteroscopy
https://reachmd.com/programs/video-library/using-endosee-diagnostic-hysteroscopy/8057/Instructional video for performing diagnostic hysteroscopy with Endosee - a truly innovative way to perform diagnostic office hysteroscopy in any room, at any site.Cracking Down on Opioid Abuse: The Pros and Cons of Stricter State Legislations
https://reachmd.com/programs/everyday-family-medicine/cracking-down-opioid-abuse-pros-cons-stricter-state-legislations/7810/States are cracking down on physicians and pharmacies in an attempt to curb a nationwide epidemic of opioid abuse. While some measures are improving the situation in hard-hit areas such as Florida, opponents say that the new laws are also keeping needed medications out of the hands of patients. HowWhy Contact Lens Hygiene Matters: Data from the CDC
https://reachmd.com/programs/everyday-family-medicine/why-contact-lens-hygiene-matters-data-from-cdc/7695/The CDC recently released the results of a national survey which found that more than 99% of contact lens wearers in the study engaged in at least one behavior that increases the risk of eye infections. Dr. Jennifer Caudle reports.